Commitment kind: unknown. Promised action: not established. Promised outcome: not established. Deadline: unknown; not assumed expired.
Occurrences
I strongly support creating a public option in our health care system, efforts to address health disparities, and policies that will address the rise of prescription drug costs.
Commits to supporting policies aimed at lowering prescription drug costs.
unverified · Source version 68763 · locator unknown
The official homepage's 'Latest News' module shows items dated June 3, 2026 and May 28, 2026, and does not show any prescription-drug-cost-related update in the June 10-12, 2026 lookback window.
Unverified model/legacy excerpt; not proof. AI summary (separate from source): No official evidence in the last 3 days that McCollum acted on prescription drug costs; the House site's latest updates stop before the lookback window.
unverified · Source version 80106 · locator unknown
Subtitle B-Prescription Drug Pricing Reform
PART 1-LOWERING PRICES THROUGH DRUG PRICE NEGOTIATION
SEC. 11001. PROVIDING FOR LOWER PRICES FOR CERTAIN HIGH-PRICED SINGLE SOURCE DRUGS.
Unverified model/legacy excerpt; not proof. AI summary (separate from source): Public Law 117-169 enacted prescription-drug-pricing reforms, including a drug price negotiation program to lower prices for certain high-priced drugs.
unverified · Source version 92095 · locator unknown
McCollum | Democratic | MN | Yea
Unverified model/legacy excerpt; not proof. AI summary (separate from source): The official House roll call shows Betty McCollum voted yea on H.R. 5376, the legislative vehicle later enacted as Public Law 117-169 with prescription-drug-pricing provisions.
unverified · Source version 92090 · locator unknown
Selected Drug List and Negotiated Prices, also known as Maximum Fair Prices in Statute (ZIP) (September 21, 2026)
Unverified model/legacy excerpt; not proof. AI summary (separate from source): Within the September 15-October 14, 2026 lookback window, CMS posted an updated official selected-drug/negotiated-price file for the Medicare Drug Price Negotiation Program.
On January 1, 2026, new negotiated maximum fair prices under the Medicare Drug Price Negotiation Program went into effect
Fetched verbatim passage. AI summary (separate from source): CMS confirms that negotiated maximum fair prices under the drug negotiation program took effect in 2026, showing implementation of a policy addressing prescription drug costs.
The Medicare Prescription Payment Plan offers Medicare Part D enrollees the option to pay out-of-pocket prescription drug costs in the form of capped monthly payments instead of all at once at the pharmacy.
Fetched verbatim passage. AI summary (separate from source): CMS' page, last modified during the lookback window, documents an active Part D payment policy that limits monthly prescription-drug cost exposure for enrollees.
unverified · Source version 80106 · locator unknown
Subtitle B—Prescription Drug Pricing Reform
PART 1—LOWERING PRICES THROUGH DRUG
PRICE NEGOTIATION
Unverified model/legacy excerpt; not proof. AI summary (separate from source): The enacted Inflation Reduction Act included a prescription drug pricing reform subtitle and a drug price negotiation part, directly delivering policy in the area McCollum pledged to support.
unverified · Source version 80106 · locator unknown
MAXIMUM MONTHLY CAP ON COST-SHARING PAYMENTS
UNDER PRESCRIPTION DRUG PLANS AND MA–PD PLANS.
Unverified model/legacy excerpt; not proof. AI summary (separate from source): The same enacted law also created a maximum monthly cap on prescription-drug cost-sharing payments, another concrete prescription-drug-cost policy outcome.
unverified · Source version 92095 · locator unknown
McCollum | Democratic | MN | Yea
Unverified model/legacy excerpt; not proof. AI summary (separate from source): The official House roll call shows McCollum voted yea on H.R. 5376, the legislative vehicle enacted as Public Law 117-169 with prescription-drug-pricing reforms.
Public state: unverifiedAs of unknown · legacy_unverified · . Original AI recommendation (not independently established): unresolved.unknown
The claim is broad and policy-oriented, but the provided evidence only shows that McCollum’s official site had no prescription-drug-cost-related update in the June 10-12, 2026 lookback window. That is not enough to establish that she delivered a specific policy outcome, made a concrete legislative push, or failed to act; it only indicates the record here is insufficient.
provider codex_cli · model gpt-5.4-mini · confidence 91%